top of page

What´s on in High flow therapy at 31st Annual Congress of the European Society of Intensive Care Med

19 oct 2018
2 min de lectura

The 31st Annual Congress of the European Society of Intensive Care Medicine is being held in Paris. I summarize the main sessions and the abstracts related to High Flow Therapy that will be presented during the congress.


Master Class:EDIC I Refresher course: Respiratory & airways management

Chair: Carl Waldmann (Reading, United Kingdom)

Chair: Hans Ulrich Rothen (Bern, Switzerland)

Role of NIV/High-flow-nasal oxygen therapy

Speaker: Luigi Camporota (London, United Kingdom)


Master Class:Mechanical Ventilation: From basics to advanced treatment

High Flow Nasal Cannula: theoretical and practical aspects, Speaker: Samir Jaber (Montpellier, France)

High-flow Oxygen or CPAP for postoperative respiratory support?

Speaker: Alexandre Demoule (Paris, France)


Cardiovascular experimental studies

Comparison of global enddiastolic volume index (GEDVI), extravascular 0

lung water index (EVLWI) and cardiac index (CI) derived from

transpulmonary thermodiltion (TPTD) during high flow vs. low/no flow

ECMO: the HEUREKA-III animal study

Abstract Presenter: Wolfgang Huber (Munich, Germany)


Clinical Trials in the ICU

Chair: Elie Azoulay (Paris, France)

Chair: Maurizio Cecconi (Milan, Italy)


L/KG/MIN: More efficient than 2 L/KG/MIN to support young infants with severe viral

bronchiolitis using high-flow nasal cannulae? Multicentre randomised controlled trial

(TRAMONTANE 2 Study)

Speaker: Christophe Milesi (Montpellier, France)


High-flow nasal oxygen vs standard oxygen in immunocompromised patients with 15:40

Acute Respiratory Failure: The HIGH Randomised Clinical Trial

Speaker: Elie Azoulay (Paris, France)


ABSTRACTS

-Nebulisation during nasal high flow therapy: a randomized clinical trial.

Abstract Presenter: Stephan Ehrmann (Tours, France)

-The predictive factors for success of high flow nasal cannula in acute hypoxemic respiratory failure patients in a regional hospital in Hong Kong.

Abstract Presenter: Chung-Tat Lun (Hong Kong, Hong Kong, China)

-High-flow nasal cannula in adults with acute respiratory failure and after extubation:

a Systematic review and meta analysis.

Abstract Presenter: Zhiheng Xu (Guangzhou, China)

-High flow oxygen therapy for the treatment of acute respiratory failure outside the

intensive care unit: feasibility, safety and efficacy.

Abstract Presenter: Giacomo Grasselli (Milan, Italy)

-Bedside ultrasound assessment of lung reaeration in patients with blunt thoracic injury receiving high-flow nasal cannula therapy: a retrospective study.

Abstract Presenter: Lu Xiao (HangZhou, China)

-High flow nasal oxygen therapy in patients with acute exacerbations of COPD.

Abstract Presenter: Burcin Halacli (Ankara, Turkey)

-Use of high flow nasal cannula therapy for acute hypoxemic respiratory failure: a review of predictors of success and outcomes.

Abstract Presenter: Ken, Jun Yang Goh (Singapore, Singapore)

-Effects of set flow rate on the ROX index in acute hypoxemic respiratory failure patients undergoing high flow therapy.

Abstract Presenter: Donatella Tortolani (Ferrara, Italy)

-Physiological evaluation of high flow oxygen therapy versus standard oxygen therapy effects in tracheostomized patients.

Abstract Presenter: Rosa Di mussi (Bari, Italy)

- Aeration changes induced by high flow nasal cannula are more homogeneous than those generated by non-invasive ventilation in healthy subjects.

Abstract Presenter: Irene Dot (Barcelona, Spain)

-Effects of nocturnal dexmedetomidine on sleep quality in critically ill patients equipped with high flow nasal cannula.

Abstract Presenter: Yoshitoyo Ueno (Tokushima, Japan)

-Non-invasive ventilation vs. high flow nasal cannula oxygenation in pneumonia-associated acute respiratory failure. An observational retrospective study.

Abstract Presenter: Sergio Rebollo (Cartagena, Spain)

-Application of the ROX index as a predictior of response to high-flow nasal cannula in patients with acute hypoxemic respiratory failure.

Abstract Presenter: Monica Magret Iglesias (Tarragona, Spain)

-The use of high flow nasal cannula oxygen outside the intensive care unit.

Abstract Presenter: Phillip Levin (Jerusalem, Israel)

- High-flow oxygen through Nasal cannula versus Continuous Positive Airway Pressure in patients with moderate hypoxemic respiratory failure due to pneumonia.

Abstract Presenter: Manuela Giovini (Piacenza, Italy)


https://www.esicm.org/events/31st-esicm-annual-congress-paris/




 
 
 

Entradas recientes

Ver todo

1 comentario


Paulo Venancio
Paulo Venancio
19 oct 2018

Hola Salvador! Estoy curioso por conocer los resultados - "Comparison Between 2l vs 3l in HFNC During the Initial Management of Severe Bronchiolitis in Infants (TRAMONTANE2)". Fuerte abrazo

Me gusta
bottom of page